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M. Selim U¨nlu¨
Detecting proteins and nanobioparticles using microarray technologies
enables resolution and sensitivity beyond the reach of ensemble
measurements.
Until about a hundred years ago, clinical diagnosis relied
mostly on medical history and physical examination. However,
there are many diseases that exhibit similar symptoms, making
it difficult to achieve direct diagnosis based on clinical
presentation. Doctors have always sought complementary
validation, and rudimentary clinical tests date back thousands of
years, when the color and odor of urine was utilized in diagnos-
tics. In modern medicine, in vitro tests are a cornerstone of clini-
cal practice, with the sensitivity of standard immunoassays mea-
suring protein biomarkers at picomolar concentrations.1 How-
ever, while this level of sensitivity is sufficient for the diagno-
sis of infectious diseases when clear symptoms are present, it
falls short—perhaps by a factor of many thousands—for the de-
tection of proteins that are important in cancer,2 neurological
disorders,3 and the early stages of infection.4 Devastating epi-
demics have exposed the limitations of current technologies, and
emphasized the importance of continuing innovation and refine-
ment of in vitro diagnostics, especially at an affordable cost.
Synergistic collaboration of medicine with engineering has
been crucial for advances in disease diagnostics. Perhaps one
of the most exciting recent technological developments in bio-
marker analysis is single-molecule counting or digital detection,
an approach that provides resolution and sensitivity beyond
the reach of ensemble measurements.5, 6 Digital detection not
only provides very high sensitivity, but also has the potential
to make the most advanced disease diagnostic tools available
at low cost. One can draw an analogy from the transition of
the audio recording industry to digital media. Prior to digital
recording, the sound quality from vinyl analog media depended
on the sophistication of the device accurately reproducing the
Figure 1. The concept of the single-particle interferometric reflectance
imaging sensor (SP-IRIS) for a diagnostic assay. (a) An unprocessed
sample (serum or whole blood, for example) suspected of containing the
target pathogens and molecular biomarkers is mixed with nanoparticle-
conjugated secondary antibodies. (b) The sample is introduced into
a microfluidic cartridge to facilitate incubation with the sensor
chip (c), which has a multiplexed array of capture probes. (d) After
incubation with the target solution, the SP-IRIS instrument captures
images, allowing for direct visualization of pathogens and nanopar-
ticle labeled individual molecules (e). This enables visualization of
individual nanoparticles and quantitative counts of multiplexed
targets. Au-NP-tagged Ab: Gold nanoparticle-tagged antibody. CCD:
Charge coupled device.
precise analog signal. Following the digital recording of audio
onto compact discs, sound quality no longer depended on the
reader because it is easier to measure the presence or absence of
a signal than to detect the absolute amount. In a similar fash-
ion, detection of single particles, when possible, is easier than
the precise measurement of the ensemble quantities.7
We demonstrated an optical imaging technique, known as the
single-particle interferometric reflectance imaging sensor
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(SP-IRIS) that can detect single nanoscale particles.8 The
technology is based on interference of light from an optically
transparent thin film—the same phenomenon that gives
rainbow colors to a soap film when illuminated by white light.
In SP-IRIS, the presence of particles modifies the interference
of light reflected from the sensor surface, producing a distinct
signal that reveals the size of the particle (which is not
otherwise visible under a conventional microscope). Using this
simple platform, we demonstrated label-free identification of
various viruses in multiplexed format in complex samples. Size
discrimination of the imaged virions allowed for rejection of
non-specifically bound particles, thus we achieved a limit-of-
detection competitive with state-of-the-art laboratory technolo-
gies. We showed simultaneous detection of Ebola and Marburg
vesicular stomatitis virus pseudotypes in serum or whole
blood9 and recently demonstrated in-liquid real-time detection
of viruses in a microfluidic cartridge.10 SP-IRIS has also shown
promising results for detection of protein11 and DNAmolecules
labeled with small gold nanoparticles, showing attomolar sensi-
tivity and meeting the requirements for most in vitro tests.
SP-IRIS offers a robust and low-cost platform for detection of
a variety of targets such as proteins, nucleic acids, and whole
viruses in a simple assay format and with high sensitivity (at
single pathogen or molecule resolution) from complex samples
with minimal sample preparation. Figure 1 shows a summary
of the concept, illustrating multiplexed detection of viruses and
molecular biomarkers. Through integration with microfluidics,
it may be possible to implement SP-IRIS for critical point-of-care
applications (such as detection of biomarkers from unprocessed
blood) for early diagnosis or sample-to-answer molecular diag-
nosis. This would be particularly advantageous for infectious
disease control and containment during an outbreak in resource-
poor rural settings.
Recently, we demonstrated the feasibility of DNA-directed
antibody immobilization for detection of individual viruses on
a microarray surface using the SP-IRIS platform.12 DNA mi-
croarrays are easier to prepare than protein microarrays and are
highly reproducible. Furthermore, DNA chips can be stored at
room temperature for an extended period of time without denat-
uration. When viral diagnostics are needed, especially in urgent
outbreak situations, the DNAmicroarrays can be functionalized
quickly.
The digital detection of proteins and nanobioparticles using
microarray technologies is poised to impact diagnostics. The
future of all analytical measurements may be based on single-
molecule detection and counting, representing the highest
achievable signal fidelity. With SP-IRIS, we have shown that
digital detection is possible at low cost.
Our continuing development efforts will target making the
detection platform and assay more robust and portable. We are
exploring a disposable passive cartridge, improving the shelf-
life of assay chips, and improvements in instrument automation,
image acquisition, and analysis. Furthermore, we are collabo-
rating with biosafety level 4 laboratories to test the detection
platform with hot virus samples.
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